The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects
Hurchla, M A, Garcia-Gomez, A, Hornick, M C, Ocio, E M, Li, A, Blanco, J F, Collins, L, Kirk, C J, Piwnica-Worms, D, Vij, R, Tomasson, M H, Pandiella, A, San Miguel, J F, Garayoa, M, Weilbaecher, K N
Published in Leukemia (01.02.2013)
Published in Leukemia (01.02.2013)
Get full text
Journal Article
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone
Ocio, E M, Fernández-Lázaro, D, San-Segundo, L, López-Corral, L, Corchete, L A, Gutiérrez, N C, Garayoa, M, Paíno, T, García-Gómez, A, Delgado, M, Montero, J C, Díaz-Rodríguez, E, Mateos, M V, Pandiella, A, Couto, S, Wang, M, Bjorklund, C C, San-Miguel, J F
Published in Leukemia (01.03.2015)
Published in Leukemia (01.03.2015)
Get full text
Journal Article
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
GARAYOA, M, GARCIA, J. L, MIGUEL, Jf San, SANTAMARIA, C, GARCIA-GOMEZ, A, BLANCO, J. F, PANDIELLA, A, HERNANDEZ, J. M, SANCHEZ-GUIJO, F. M, DEL CANIZO, M.-C, GUTIERREZ, N. C
Published in Leukemia (01.08.2009)
Published in Leukemia (01.08.2009)
Get full text
Journal Article
P848: TINOSTAMUSTINE (EDO‐S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA
Diaz‐Tejedor, A., San‐Segundo, L., Corchete, L. A., González‐Méndez, L., Martín‐Sánchez, M., Lorenzo‐Mohamed, M., González‐Rodríguez, M., Cruz‐Hernández, M., Sánchez‐Blázquez, M., Gutiérrez, N. C., Mateos, M.‐V., Garayoa, M., Ocio, E. M., Paíno, T.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Preclinical Antimyeloma Activity of EDO-S101
Lopez-Iglesia, A.A, San-Segundo, L, Herrero, A.B, González, L, Hernández, S, Primo, D, Paíno, T, Martín, M, Algarín, M, Garayoa, M, Mehrling, T, San Miguel, J.F, Mateos, M.V, Ocio, E.M
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Filanesib (ARRY-520) Demonstrates Potent and Rapid Activity in Preclinical Models of MM, Dependent on Bcl-2 Family Expression, and Synergistic with Dexamethasone and IMiDs
Hernández-García, S, San-Segundo, L, González-Méndez, L, Paíno, T, López-Iglesias, A.A, Martín-Sánchez, M, Algarín, E.M, Garayoa, M, Humphries, M.J, Tunquist, B, San-Miguel, J.F, Mateos, M.V, Ocio, E.M
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
The novel pan-PIM kinase inhibitor, LGH447, shows dual antitumoral and bone antiresorptive effect in multiple myeloma and synergizes with standard-of-care treatments
Paíno, T, García-Gómez, A, González-Méndez, L, San-Segundo, L, Hernández-García, S, López-Iglesias, A.-A, Algarín, E.M, Martín-Sánchez, M, González, D.C, Ortiz de Solorzano, C, Corchete, L, Vanasse, G, Gutiérrez, N.C, Mateos, M.-V, San-Miguel, J.F, Garayoa, M, Ocio, E.M
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Alternative splicing of the proadrenomedullin gene results in differential expression of gene products
Martinez, A, Hodge, DL, Garayoa, M, Young, HA, Cuttitta, F
Published in Journal of molecular endocrinology (01.08.2001)
Published in Journal of molecular endocrinology (01.08.2001)
Get full text
Journal Article
Expression of Proadrenomedullin Derived Peptides in the Mammalian Pituitary: Co-Localization of Follicle Stimulating Hormone and Proadrenomedullin N-20 Terminal Peptide-Like Peptide in the Same Secretory Granules of the Gonadotropes
Montuenga, L M, Burrell, M A, Garayoa, M, Llopiz, D, Vos, M, Moody, T, García-Ros, D, Martínez, A, Villaro, A C, Elsasser, T, Cuttitta, F
Published in Journal of neuroendocrinology (01.07.2000)
Published in Journal of neuroendocrinology (01.07.2000)
Get full text
Journal Article
In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma
Ocio, Enrique M, Vilanova, David, Atadja, Peter, Maiso, Patricia, Crusoe, Edvan, Fernández-Lázaro, Diego, Garayoa, Mercedes, San-Segundo, Laura, Hernández-Iglesias, Teresa, de Alava, Enrique, Shao, Wenlin, Yao, Yung-Mae, Pandiella, Atanasio, San-Miguel, Jesús F
Published in Haematologica (Roma) (01.05.2010)
Published in Haematologica (Roma) (01.05.2010)
Get full text
Journal Article
CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype
PAINO, Teresa, OCIO, Enrique M, PAIVA, Bruno, SAN-SEGUNDO, Laura, GARAYOA, Mercedes, GUTIERREZ, Norma C, SARASQUETE, M. Eugenia, PANDIELLA, Atanasio, ORFAO, Alberto, MIGUEL, Jesus F. San
Published in Haematologica (Roma) (01.07.2012)
Published in Haematologica (Roma) (01.07.2012)
Get full text
Journal Article
The Hybrid Molecule, Edo-S101, Impairs Double Strand Breaks Repair in Multiple Myeloma and Synergizes with Bortezomib and Dexamethasone
López-Iglesias, Ana Alicia, Herrero, Ana Belen, San-Segundo, Laura, Hernández-García, Susana, González-Méndez, Lorena, Martín-Sánchez, Montserrat, Algarín, Esperanza M, Paino, Teresa, Garayoa, Mercedes, Mehrling, Thomas, Gutierrez, Norma C, San-Miguel, Jesús F., Mateos, Maria-Victoria, Ocio, Enrique M.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Expression of complement factor H by lung cancer cells: Effects on the activation of the alternative pathway of complement
AJONA, Daniel, CASTANO, Zafira, GARAYOA, Mercedes, ZUDAIRE, Enrique, PAJARES, Maria J, MARTINEZ, Alfredo, CUTTITTA, Frank, MONTUENGA, Luis M, PIO, Ruben
Published in Cancer research (Chicago, Ill.) (01.09.2004)
Published in Cancer research (Chicago, Ill.) (01.09.2004)
Get full text
Journal Article
Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients
VICENT, Silvestre, GARAYOA, Mercedes, LOPEZ-PICAZO, José M, LOZANO, Maria D, TOLEDO, Gemma, THUNNISSEN, Frederik B. J. M, MANZANO, Ramon G, MONTUENGA, Luis M
Published in Clinical cancer research (01.06.2004)
Published in Clinical cancer research (01.06.2004)
Get full text
Journal Article